Literature DB >> 1979584

Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.

S Oshima1, D D Eckels.   

Abstract

Ag-dependent activation of human T cells results in high level expression of class II MHC molecules. As part of this process, Ag recognition by TCR generates a series of second signals including protein kinase C, tyrosine kinase, and Ca2+ mobilization. To investigate the role of these second messengers in class II MHC expression, purified T cells were first stimulated by PMA, ionomycin, OKT3 accompanied by IL-2, or the mitogenic anti-CD2 antibodies T112 and T113 and were then stained with FITC-conjugated anti-class I and -class II MHC antibodies for analysis by flow cytometry. OKT3 and IL-2 induced optimal expression of HLA-DR (DR) on 70% of T cells with high density. Despite their high mitogenicity, induction of class II MHC expression by PMA, even with co-stimulation by ionomycin, was reduced to less than 20% of T cells, with an intensity 50-fold lower than in OKT3/IL-2-stimulated T cells. Furthermore, PMA inhibited class II MHC expression by OKT3/IL-2-stimulated T cells in a dose-dependent manner and additional stimuli, such as IL-1, IL-4, IFN-gamma, TCR cross-linkers, or monocytes, did not restore class II MHC expression by PMA-activated T cells. DR beta mRNA analysis showed that the low induction of class II molecules by PMA extends to the transcriptional level. Interestingly, anti-T112 and anti-T113 induced not only proliferation of T cells but also DR expression on more than 90% of T cells. These results indicate that transduction of a specific signal, probably selective phosphorylation of the CD3 molecule, contributes to class II MHC induction in the process of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979584

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Authors:  Anita H Undale; Peter J van den Elsen; Esteban Celis
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

2.  Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements.

Authors:  G K Matsushima; Y Itoh-Lindstrom; J P Ting
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.

Authors:  Cristina Maria Costantino; Hidde L Ploegh; David A Hafler
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

4.  The control of class II expression on T cells is independent of the regulation of Tac and the induction of proliferation.

Authors:  S Salvadori; A Pizzimenti; S Cohen; K S Zier
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

5.  CD8+HLADR+ Regulatory T Cells Change With Aging: They Increase in Number, but Lose Checkpoint Inhibitory Molecules and Suppressive Function.

Authors:  Stella Lukas Yani; Michael Keller; Franz Leonard Melzer; Birgit Weinberger; Luca Pangrazzi; Sieghart Sopper; Klemens Trieb; Monia Lobina; Valeria Orrù; Edoardo Fiorillo; Francesco Cucca; Beatrix Grubeck-Loebenstein
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

6.  Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment.

Authors:  Amber M Johnson; Jennifer M Boland; Julia Wrobel; Emily K Klezcko; Mary Weiser-Evans; Katharina Hopp; Lynn Heasley; Eric T Clambey; Kimberly Jordan; Raphael A Nemenoff; Erin L Schenk
Journal:  J Thorac Oncol       Date:  2021-05-25       Impact factor: 20.121

7.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.

Authors:  E A Ranheim; T J Kipps
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.